| scholarly article | Q13442814 |
| P2093 | author name string | van Loon AM | |
| Verdonck LF | |||
| Meijer E | |||
| Boland GJ | |||
| Thijsen SF | |||
| Moschatsis S | |||
| Spijkers S | |||
| P2860 | cites work | Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers | Q24541318 |
| Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. | Q33182312 | ||
| Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation | Q33183745 | ||
| Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants | Q35001143 | ||
| Diagnosing herpesvirus infections by real-time amplification and rapid culture. | Q39733154 | ||
| Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification | Q40990072 | ||
| Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors | Q44119547 | ||
| Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts | Q44544710 | ||
| P433 | issue | 1 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 4-10 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Transplant Infectious Disease | Q15749562 |
| P1476 | title | Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation? | |
| P478 | volume | 7 |
| Q53661299 | Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient. |
| Q34055365 | Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency |
| Q42943070 | Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay |
| Q40634214 | Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study |
| Q36530296 | Epstein-Barr virus in oral diseases |
| Q45404352 | Epstein-Barr virus infection after unrelated cord blood transplantation: reactivation or reinfection? |
| Q43689745 | Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders |
| Q44946202 | Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients |
| Q40455103 | Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. |
| Q37148363 | Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. |
| Q59350417 | Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus |
| Q89527241 | Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis |
Search more.